Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro
Authors:
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Prostaglandin E2 Directly Inhibits Bone-Resorbing Activity of Isolated Mature Osteoclasts Mainly Through the EP4 ReceptorCalcified Tissue International, 2000
- Knockout of the Murine Prostaglandin EP2 Receptor Impairs Osteoclastogenesis in Vitro*Endocrinology, 2000
- Impaired Bone Resorption to Prostaglandin E2 in Prostaglandin E Receptor EP4-knockout MiceJournal of Biological Chemistry, 2000
- Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in cultureJournal of Clinical Investigation, 2000
- The utilization of recombinant prostanoid receptors to determine the affinities and selectivities of prostaglandins and related analogsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2Journal of Endocrinology, 1998
- Molecular Cloning and Expression of a Rat Prostaglandin E2 Receptor of the EP2 SubtypeProstaglandins, 1997
- Expression of prostaglandin E receptor subtypes in bone: Expression of EP2 in bone developmentBone, 1995
- Triazolinone Biphenylsulfonamide Derivatives as Orally Active Angiotensin II Antagonists with Potent AT1 Receptor Affinity and Enhanced AT2 AffinityJournal of Medicinal Chemistry, 1994
- Prostaglandins promote osteoclastlike cell formation by a mechanism involving cyclic adenosine 3′,5′-monophosphate in mouse bone marrow cell culturesJournal of Bone and Mineral Research, 1989